Adaptive Biotechnologies Corporation (ADPT)
NASDAQ · Healthcare
Adaptive Biotechnologies Corporation Net Income 2017–2025
Adaptive Biotechnologies Corporation annual/quarterly net income history and growth rate from 2017 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Adaptive Biotechnologies Corporation net income for the quarter ending March 31, 2026 was -20.0 M, a 32.89% decrease year-over-year.
- Adaptive Biotechnologies Corporation net income for the twelve months ending March 31, 2026 was -66.0 M, a 62.55% decrease year-over-year.
- Adaptive Biotechnologies Corporation annual net income for 2025 was -59.5 M, a 62.69% decrease from 2024.
- Adaptive Biotechnologies Corporation annual net income for 2024 was -159.5 M, a 29.19% decrease from 2023.
- Adaptive Biotechnologies Corporation annual net income for 2023 was -225.3 M, a 12.52% increase from 2022.
- Adaptive Biotechnologies Corporation annual net income for 2022 was -200.2 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Adaptive Biotechnologies Corporation Net Income — FAQ
Adaptive Biotechnologies Corporation (ADPT) net income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Adaptive Biotechnologies Corporation's net income?
Adaptive Biotechnologies Corporation (ADPT) reported net income of -$59M for fiscal 2025.
Where can I see ADPT's net income history?
The chart and table above show Adaptive Biotechnologies Corporation's net income by year and by quarter, including the growth rate.